TRINEX Tablet by Dr Precision is a precisely formulated pharmaceutical product containing Tranexamic Acid, manufactured by BluepillExpress under globally certified third-party facilities. This antifibrinolytic agent is specially designed for use in clinical settings to prevent or reduce excessive bleeding caused by abnormal fibrinolysis. TRINEX achieves hemostasis by inhibiting the conversion of plasminogen to plasmin, thus stabilizing blood clots without altering platelet function or coagulation time. Ideal for professionals treating heavy menstrual bleeding (menorrhagia), bleeding in hemophilic dental patients, postoperative bleeding, epistaxis, and trauma-related bleeding, TRINEX offers a reliable and non-hormonal therapeutic option. Manufactured under strict WHO-GMP, ISO 9001:2015, and cGMP certified conditions, it ensures consistent quality, safety, and efficacy. The product is available typically in 500 mg or 650 mg dosages, supplied in aluminum-PVC or Alu-Alu blister strips designed for easy handling, transportation, and regulatory compliance. With extensive quality testing including assay uniformity, dissolution, microbial limits, and residual solvent analysis, TRINEX is suited for bulk pharmaceutical use and international export, supported by comprehensive documentation such as COA, COPP, MSDS, and stability data. Healthcare professionals value TRINEX for its high bioavailability, minimal side effects, and no interference with ovulation, making it an optimal choice in the management of bleeding disorders in clinical practice and hospital pharmacies worldwide.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tranexamic Acid (500 mg or 650 mg) |
| Therapeutic Class | Antifibrinolytic agent |
| Mechanism of Action | Inhibits plasminogen activation to plasmin, preventing fibrin degradation |
| Indications | Heavy menstrual bleeding, dental bleeding in hemophilia, epistaxis, postoperative bleeding, trauma-induced bleeding |
| Manufacturing Standards | WHO-GMP, ISO 9001:2015, cGMP certified, Schedule M compliant |
| Packaging | Aluminum-PVC or Alu-Alu blister strips, 10 tablets per strip |
| Quality Assurance Tests | Assay and content uniformity, dissolution, microbial limits, residual solvent, packaging integrity |
| Non-Hormonal | Does not affect ovulation or fertility |
| Bioavailability | High oral bioavailability and gastric tolerability |
| Export Ready | Includes COA, COPP, MSDS, Stability Data, Product Dossier in CTD/eCTD formats |
| Attributes | Description |
|---|---|
| Formulation Type | Oral Tablet |
| Dosage Strengths | 500 mg, 650 mg Tranexamic Acid |
| Dosage Form | Film-coated tablet |
| Manufacturer | BluepillExpress (Dr Precision label) |
| Storage Conditions | Store in a cool, dry place away from sunlight |
| Shelf Life | As per regulatory guidelines, typically 24 months |
| Packing Details | 10 tablets per blister strip, aluminum-PVC or Alu-Alu |
| Compliance | WHO-GMP, ISO 9001:2015, cGMP, Schedule M |
| Product Documentation | COA, COPP, MSDS, Stability and Dossier available |
| Common Side Effects | Nausea, diarrhea, headache, visual disturbances (mild and rare) |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
TRINEX Tablet stabilizes blood clots by inhibiting fibrinolysis without affecting platelet count, making it effective for managing bleeding in hemophilic dental procedures where controlling fibrinolysis is critical.
Yes, TRINEX Tablet is indicated for heavy menstrual bleeding and is also prescribed pre- and post-operatively to minimize blood loss during surgical procedures including orthopedic and cardiac surgeries.
Quality is ensured by manufacturing in WHO-GMP and ISO-certified facilities with strict compliance to Schedule M. Each batch undergoes assay, dissolution, microbial testing, residual solvent analysis, and packaging validation.
Yes, dosing should be adjusted under medical supervision for patients with renal impairment to avoid accumulation and potential adverse effects.
No, as a non-hormonal antifibrinolytic, TRINEX does not interfere with ovulation or fertility, making it a preferred treatment in reproductive-age women.
TRINEX is available in blister packs of 10 tablets per strip with options for aluminum-PVC or Alu-Alu packaging, including multilingual labeling and regulatory documentation for export.
Country Of Origin: India
TRINEX Tablet is a pharmaceutical formulation containing Tranexamic Acid, a synthetic derivative of the amino acid lysine. It is primarily used as an antifibrinolytic agent to prevent or reduce excessive bleeding in various clinical conditions such as heavy menstrual bleeding, dental procedures in hemophiliacs, and postoperative bleeding. Manufactured by BluepillExpress under globally certified third-party facilities, TRINEX ensures consistent efficacy, safety, and quality in hemostatic therapy.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
TRINEX Tablet is a trusted hemostatic agent containing Tranexamic Acid, available in doses such as 500 mg or 650 mg depending on clinical application. Developed by BluepillExpress, a reputed name in global pharmaceutical third-party manufacturing and exports, this tablet is formulated to deliver reliable antifibrinolytic action, ensuring controlled and efficient management of bleeding disorders.
Tranexamic Acid works by inhibiting the activation of plasminogen to plasmin, thereby preventing fibrin degradation and stabilizing blood clots. It is particularly useful in conditions where excessive fibrinolysis is the root cause of bleeding. As a non-hormonal treatment, it is widely preferred in menorrhagia, epistaxis, tooth extractions, and various surgical or trauma-related bleeding conditions.
Manufacturing Excellence by BluepillExpress:
TRINEX Tablet is produced in WHO-GMP, ISO 9001:2015, and cGMP certified facilities, strictly following Schedule M guidelines. Each batch undergoes meticulous quality checks, including:
Assay and content uniformity testing
Dissolution profiling
Microbial limit tests
Residual solvent analysis
Packaging integrity validation
These robust protocols ensure the purity, potency, and bioavailability of every TRINEX Tablet manufactured for local and international markets.
Pharmacological Profile:
Tranexamic Acid is a synthetic antifibrinolytic agent that exerts its effect by blocking lysine binding sites on plasminogen molecules, thereby reducing the dissolution of fibrin clots. This makes it effective for a wide range of bleeding scenarios without affecting platelet count or clotting time.
Indications:
Heavy menstrual bleeding (Menorrhagia)
Bleeding associated with dental procedures in hemophilia
Epistaxis (nosebleeds)
Postpartum hemorrhage
Surgical bleeding (orthopedic, gynecological, cardiac, etc.)
Hereditary angioedema (off-label use)
Trauma-related internal bleeding (with medical supervision)
Dosage & Administration:
Menorrhagia: 500 mg to 1000 mg three times daily for up to 5 days
Surgical bleeding prevention: 1000 mg prior to surgery, then 3-4 times daily post-op
Dental extraction in hemophiliacs: As per specialist recommendation
Note: Dosage should be customized by a healthcare professional based on the bleeding condition, renal function, and patient history.
Why Choose TRINEX Tablet by BluepillExpress:
Non-hormonal treatment for menstrual bleeding
No interference with ovulation or fertility
Minimizes need for blood transfusion postoperatively
High oral bioavailability and gastric tolerability
Bulk manufacturing and custom branding available
Product Packaging & Export-Ready Compliance:
BluepillExpress offers TRINEX in blister or strip packing, typically:
10 tablets per strip
Aluminum-PVC or Alu-Alu packaging
Multilingual labels and patient information leaflets
Compliant with country-specific registration and regulatory needs
With international experience in supplying to Asia, Africa, CIS, Middle East, and Latin America, BluepillExpress ensures complete documentation including:
Certificate of Analysis (COA)
Certificate of Pharmaceutical Product (COPP)
MSDS
Stability Data
Product Dossier (CTD/eCTD format on request)
Precautions & Contraindications:
Use with caution in patients with renal impairment (dose adjustment required)
Not recommended in patients with active thromboembolic disease
May cause mild side effects like nausea, diarrhea, headache, or visual disturbances
Avoid in patients with a history of seizures
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
